The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
Honda Motor Co.
HMC · NYSE (ADR) · USD · Market cap $40.6B · 195,109 employees
Honda Motor Co., Ltd.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Honda Motor Co. holds its Markup at $31.30. Consolidating, no directional conviction, held for 205 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 205 days |
| Price at the screen | $31.30 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.31 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 14.37% | Below 33% | Interest-bearing debt is just 14.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 14.72% | Below 33% | Cash held in interest-bearing accounts and securities is 14.7% of assets, under the one-third limit. | Pass |
| Receivables | 20.06% | Below 49% | Money owed to the company is 20.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.62% | Below 5% | Only 0.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 2% discount to our $32.00 fair value, 13.50% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 2.2% margin of safety to the base estimate.
Third-party analyst targets: 3 covering, consensus Hold. The average target sits +2% from the screen price.
Reading the gap · Our model and the Street both land near today's price: fairly valued, with no strong edge either way.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsHonda's Cheap Multiple Hides Cycle Trap
Think of Honda as the family saloon that still starts on a cold morning when rivals have already stalled. Its forward earnings multiple sits at just 5.7 times while revenue edges up 9 percent, and the ethical screen gives it a clean pass, which is why the name registers as an opportunity against a $32 fair value.
Yet autos are the textbook cyclical sector where a depressed multiple rarely signals a bargain. Negative profit margins of 2 percent and a negative 3 percent return on equity show the current cycle is already hurting operations, not setting up an easy recovery.
That combination is the classic value trap warning. Low multiples here usually reflect peak or fading earnings rather than undervalued strength, so any rebound hinges on factors outside the company's control.
Analysis, not advice.
| EPS, trailing | -0.71 |
| Revenue growth | +13.5%steady growth |
| Profit margin | -0.8%currently unprofitable |
| Return on equity | -0.8%not currently earning a positive return on equity |
| FCF yield | 659.22% |
| Dividend yield | 504.00% |
| Debt to equity | 1.14a meaningful debt load worth watching |
| Current ratio | 1.29adequate liquidity, worth monitoring |
| Beta | 0.31barely tracks the market's swings |
| Short interest, float | 0.00% |
| 52-week range | 23.25 - 34.44 |
| Market cap | $40.6B |
| Employees | 195,109 |
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeHMC trades on NYSE (ADR) (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- All the EVs that were discontinued or killed off in the U.S. this year TechCrunch · 18 Jul 2026
- Honda (TSE:7267) Is Ending Prologue EV Sales In The U.S. To Back Hybrids Simply Wall St. · 17 Jul 2026
- Honda ending U.S. sales of Prologue electric vehicle Quartz · 17 Jul 2026
- Nvidia Pushes Into a Big New AI Market That Could Rally the Stock Barrons.com · 16 Jul 2026
- Sector Update: Consumer Stocks Rise Late Afternoon MT Newswires · 16 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $23.98 | +9.7% | · | $1,097 | +9.7% |
| 2 months | $24.04 | +9.5% | · | $1,095 | +9.5% |
| 3 months | $26.09 | +0.9% | · | $1,009 | +0.9% |
| 6 months | $30.82 | -14.6% | · | $854 | -14.6% |
| 1 year | $29.28 | -10.1% | · | $899 | -10.1% |
| 2 years | $31.30 | -15.9% | $1.39 | $885 | -11.5% |
| 3 years | $28.30 | -7.0% | $2.72 | $1,026 | +2.6% |
| 5 years | $28.55 | -7.8% | $4.48 | $1,079 | +7.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HMC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.